` 303810 (DongKook Life Science Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

D
303810
vs
K
KOSPI 200

Over the past 12 months, DongKook Life Science Co Ltd has underperformed KOSPI 200, delivering a return of +13% compared to KOSPI 200's +116% growth.

Stocks Performance
303810 vs KOSPI 200

Loading...
303810
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
303810 vs KOSPI 200

Performance Gap Between 303810 and KOSPI200
LOCKED
Unlock

Performance By Year
303810 vs KOSPI 200

Loading...
303810
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
DongKook Life Science Co Ltd vs Peers

KOSPI 200
303810
LLY
JNJ
MRK
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

DongKook Life Science Co Ltd
Glance View

Market Cap
89.7B KRW
Industry
Pharmaceuticals

DongKook Life Science Co., Ltd. engages in the manufacturing and selling of pharmaceutical products and distributing medical devices and diagnostic equipment. The company is headquartered in Seoul, Seoul and currently employs 203 full-time employees. The company went IPO on 2025-02-17. The firm is principally engaged in the production and sale of contrast agents such as X-ray contrast agents, magnetic resonance imaging (MRI) contrast agents as well as others. In addition, the Company is engaged in the distribution and sale of medical equipment and medical devices.

Intrinsic Value
Not Available
Back to Top